Dashboard
Manage Tickers

SLRXSalarius Pharmaceuticals, Inc.

Nasdaq salariuspharma.com


$ 2.53 $ 0.03 (1.24 %)    

Tuesday, 25-Jun-2024 15:38:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 2.4501
$ 2.48
$ 0.00 x 0
$ 0.00 x 0
$ 2.35 - $ 2.66
$ 2.30 - $ 12.48
230,277
na
1.28M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-27-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-18-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-23-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 07-17-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 03-06-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 03-07-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 03-08-2017 12-31-2016 10-K
31 11-02-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 03-08-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-06-2015 03-31-2015 10-Q
38 03-24-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-vuzix-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Vuzix Shares Are Trading Higher By Aro...
06/20/2024 12:22:52

salarius-pharmaceuticals-announces-md-anderson-cancer-center-presents-clinical-data-on-seclidemstat-for-mds-and-cmml-at-2024-european-hematology-association-congress
Salarius Pharmaceuticals Announces MD Ande...
06/17/2024 12:03:36

Patients were treated in the dose-escalation portion of the Phase 1/2 study evaluating seclidemstat in combination with azaciti...

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/14/2024 23:50:04

salarius-pharmaceuticals-announces-1-for-8-reverse-stock-split-will-trade-on-a-split-adjusted-basis-on-june-17-2024
Salarius Pharmaceuticals Announces 1-For-8...
06/12/2024 12:01:41

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein d...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/10/2024 20:31:12

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
06/07/2024 20:31:12

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/27/2024 16:31:07

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
03/25/2024 13:05:53

why-salarius-pharmaceuticals-shares-are-trading-higher-by-around-31-here-are-20-stocks-moving-premarket
Why Salarius Pharmaceuticals Shares Are Tr...
03/25/2024 12:03:24

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter re...

salarius-pharmaceuticals-shares-are-trading-higher-after-the-company-reported-q4-financial-results
Salarius Pharmaceuticals shares are tradin...
03/25/2024 11:45:49

dada-nexus-salarius-pharmaceuticals-and-3-stocks-to-watch-heading-into-monday
Dada Nexus, Salarius Pharmaceuticals And 3...
03/25/2024 06:50:33

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as foll...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/22/2024 21:33:05

salarius-pharmaceuticals-q4-2023-gaap-eps-022-beats-101-estimate
Salarius Pharmaceuticals Q4 2023 GAAP EPS ...
03/22/2024 20:07:35

Salarius Pharmaceuticals (NASDAQ:SLRX) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate...

salarius-provides-update-on-strategic-review-process-and-plans-to-support-ongoing-seclidemstat-clinical-trials-by-further-reducing-expenses-implementing-a-series-of-cost-savings-measures-designed-to-extend-expected-cash-runway-into-the-first-half-of-2025
Salarius Provides Update On Strategic Revi...
02/22/2024 13:05:15

Company implementing a series of cost-savings measures designed to extend Salarius' expected cash runway into the first hal...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/01/2024 13:06:10

why-datchat-shares-are-trading-lower-by-around-33-here-are-20-stocks-moving-premarket
Why DatChat Shares Are Trading Lower By Ar...
01/17/2024 13:18:56

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offe...

salarius-pharmaceuticals-issued-us-patent-no-11773080-titled-deuterium-enriched-isoindolinonyl-azepanediones-and-related-compounds-and-methods-of-treating-medical-disorders-using-same
Salarius Pharmaceuticals Issued U.S. Paten...
01/16/2024 13:16:25

Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues Protein degrader portfolio now i...

investigator-initiated-phase-12-clinical-trial-using-salarius-pharmaceuticals-seclidemstat-in-combination-with-azacitidine-to-treat-hematologic-cancers-resumes-patient-enrollment
Investigator-Initiated Phase 1/2 Clinical ...
01/03/2024 13:44:37

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) announces that the hematologic cancer Phase 1/2 clinical trial being conducted at ...

salarius-completes-fda-type-b-meeting-for-seclidemstat-ewing-sarcoma-development-program
Salarius Completes FDA Type B Meeting For ...
11/07/2023 13:30:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)